Daniel Fuentes, PharmD

Scientific Director, Medical Affairs - Neonatology
Chiesi USA

Poster(s):

• Surfactant Therapy Rates of Preterm Infants in the United States, 2020–2024: Evidence from CDC WONDER Natality and the Premier Healthcare Database
  Monday, April 27, 2026

  8:00am - 10:00am ET

• Comparative Safety of LISA in Preterm Neonates with RDS: A Systematic Review and Meta-Analysis
  Sunday, April 26, 2026

  9:30am - 11:30am ET